1. Home
  2. CHWY vs BLCO Comparison

CHWY vs BLCO Comparison

Compare CHWY & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chewy Inc.

CHWY

Chewy Inc.

N/A

Current Price

$21.20

Market Cap

8.8B

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$19.97

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHWY
BLCO
Founded
2010
1853
Country
United States
Canada
Employees
N/A
13000
Industry
Catalog/Specialty Distribution
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.1B
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
CHWY
BLCO
Price
$21.20
$19.97
Analyst Decision
Buy
Buy
Analyst Count
26
15
Target Price
★ $28.64
$21.64
AVG Volume (30 Days)
★ 7.0M
849.4K
Earning Date
12-09-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.42
N/A
Revenue
★ $12,601,500,000.00
$5,101,000,000.00
Revenue This Year
$7.32
$7.83
Revenue Next Year
$6.75
$5.90
P/E Ratio
$49.71
★ N/A
Revenue Growth
6.24
★ 6.47
52 Week Low
$17.40
$14.44
52 Week High
$37.34
$21.36

Technical Indicators

Market Signals
Indicator
CHWY
BLCO
Relative Strength Index (RSI) 53.94 74.71
Support Level $19.78 $15.30
Resistance Level $22.31 N/A
Average True Range (ATR) 0.78 0.69
MACD 0.09 0.41
Stochastic Oscillator 56.77 77.03

Price Performance

Historical Comparison
CHWY
BLCO

About CHWY Chewy Inc.

Founded in 2011, Chewy is a leading e-commerce retailer of pet food, toys, supplies, and medications in North America. The firm offers a comprehensive selection of proprietary and third-party brands, anchored by its highly sticky autoship subscription program, which drives over 83% of its sales. Beyond core retail, Chewy is expanding into high-margin revenue streams, including its retail media network (Chewy Ads), specialized veterinary healthcare software, and brick-and-mortar veterinary clinics to further integrate customers into the Chewy ecosystem.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.

Share on Social Networks: